PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
AACT 109 Target Target A1AT 329 1 0.01 -0.99 0.01 0.70
AACT 109 Target Target Toll-Like Receptor 2 2,174 1 0.00 -1.00 0.01 0.64
AACT 109 Target Target AFP 9,751 1 0.00 -1.00 0.01 0.60
AACT 109 Target Disease Hypocalcemia 6,174 1 0.00 -1.00 0.01 0.61
AACT 109 Target Disease Anxiety Disorder 8,985 1 0.00 -1.00 0.01 0.60
AACT 109 Target Disease Lung Carcinoma 13,423 1 0.00 -1.00 0.01 0.59
AACT 109 Target Disease Menopause 19,680 1 0.00 -1.00 0.01 0.58
AACT 109 Target Disease Liver Disease 49,817 1 0.00 -1.00 0.01 0.56
AACT 109 Target Disease Hepatitis B 57,815 1 0.00 -1.00 0.01 0.56
AACT 109 Target Disease Sepsis 64,798 1 0.00 -1.00 0.01 0.55
AACT 109 Target Disease Lung Cancer 91,416 1 0.00 -1.00 0.01 0.55
AACT 109 Target Disease Asthma 109,610 1 0.00 -1.00 0.01 0.54
AACT 109 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.01 0.54
AACT 109 Target Disease Shock 134,031 1 0.00 -1.00 0.01 0.54
AACT 109 Target Disease Breast Cancer 173,695 1 0.00 -1.00 0.01 0.53
A1M 59 Target Target Endoglin 1,333 1 0.00 -0.99 0.02 0.67
A1M 59 Target Target AGP 2,006 1 0.00 -0.99 0.02 0.65
A1M 59 Target Target Elastase 13,875 1 0.00 -0.99 0.02 0.60
A1M 59 Target Disease Kidney Diseases 4,651 1 0.00 -0.99 0.02 0.63
A1M 59 Target Disease Mesothelioma 11,198 1 0.00 -0.99 0.02 0.61
A1M 59 Target Disease Organ Transplantation 11,384 1 0.00 -0.99 0.02 0.61
A1M 59 Target Disease Bacterial Infections 14,248 1 0.00 -0.99 0.02 0.60
A1M 59 Target Disease Glomerulonephritis 23,459 1 0.00 -0.99 0.02 0.59
A1M 59 Target Disease Ulcers 45,142 1 0.00 -0.99 0.02 0.57
A1M 59 Target Disease Renal Failure 73,993 1 0.00 -0.99 0.02 0.56
A1M 59 Target Disease Shock 134,031 1 0.00 -0.99 0.02 0.55
A1AT 329 Target Target Macrophage Metalloelastase 100 1 0.01 -0.99 0.01 0.70
A1AT 329 Target Target CALR 117 1 0.01 -0.99 0.01 0.70
A1AT 329 Target Target APOA2 118 1 0.01 -0.99 0.01 0.70
A1AT 329 Target Target Proteinase-Activated Receptor 1 133 1 0.00 -0.99 0.01 0.70
A1AT 329 Target Target APOA1 958 1 0.00 -1.00 0.00 0.65
A1AT 329 Target Target CER 2,421 1 0.00 -1.00 0.00 0.62
A1AT 329 Target Target CD95 4,266 1 0.00 -1.00 0.00 0.60
A1AT 329 Target Target Alpha-Amylase 7,171 1 0.00 -1.00 0.00 0.59
A1AT 329 Target Target CD34 24,598 1 0.00 -1.00 0.00 0.56
A1AT 329 Target Target EGF 27,487 1 0.00 -1.00 0.00 0.55
A1AT 329 Target Disease Rare Diseases 2,212 1 0.00 -1.00 0.00 0.62
A1AT 329 Target Disease Warts 5,574 1 0.00 -1.00 0.00 0.59
A1AT 329 Target Disease Ileus 9,091 1 0.00 -1.00 0.00 0.58
A1AT 329 Target Disease Acute Coronary Syndromes 9,133 1 0.00 -1.00 0.00 0.58
A1AT 329 Target Disease Ankylosing Spondylitis 9,665 1 0.00 -1.00 0.00 0.58
A1AT 329 Target Disease Respiratory Tract Infections 9,721 1 0.00 -1.00 0.00 0.58
A1AT 329 Target Disease Down Syndrome 10,290 1 0.00 -1.00 0.00 0.58
A1AT 329 Target Disease Bacterial Infections 14,248 1 0.00 -1.00 0.00 0.57
A1AT 329 Target Disease Nephrotic Syndrome 14,681 1 0.00 -1.00 0.00 0.57
A1AT 329 Target Disease Menopause 19,680 1 0.00 -1.00 0.00 0.56
A1AT 329 Target Disease Proteinuria 28,803 1 0.00 -1.00 0.00 0.55
A1AT 329 Target Disease Renal Failure 73,993 1 0.00 -1.00 0.00 0.53
A1AT 329 Target Disease Anemia 81,663 1 0.00 -1.00 0.00 0.53
A1AT 329 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.00 0.52
A-Methapred (Methylprednisolone Sodium Succinate)- FDA 1 Drug Drug Adalimumab (Humira)- FDA 62 1 0.13 -0.70 1.00 0.82
744.1 22 Target Target 464.1 19 1 0.05 -0.95 0.05 0.83
744.1 22 Target Target Adiponectin 11,994 1 0.00 -0.98 0.05 0.62
744.1 22 Target Disease Acute Promyelocytic Leukemia 4,780 1 0.00 -0.98 0.05 0.64
744.1 22 Target Disease Dyslipidemia 15,225 1 0.00 -0.98 0.05 0.61
744.1 22 Target Disease Chronic Obstructive Pulmonary Disease 27,780 1 0.00 -0.98 0.05 0.60
744.1 22 Target Disease Liver Disease 49,817 1 0.00 -0.98 0.05 0.59
744.1 22 Target Disease Stroke 146,992 1 0.00 -0.98 0.05 0.56
744.1 22 Target Disease Leukemia 162,805 1 0.00 -0.98 0.05 0.56
744.1 22 Target Disease Hepatitis 163,842 1 0.00 -0.98 0.05 0.56
744.1 22 Target Disease Carcinoma 433,099 1 0.00 -0.98 0.05 0.54
5-Hydroxytryptamine 2b Receptor 18 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.03 -0.96 0.06 0.79
5-Hydroxytryptamine 2b Receptor 18 Target Target D(2) Dopamine Receptor 1,559 1 0.01 -0.97 0.06 0.68
5-Hydroxytryptamine 2b Receptor 18 Target Target Elastase 13,875 1 0.00 -0.97 0.06 0.62
5-Hydroxytryptamine 2b Receptor 18 Target Target ERK1 18,374 1 0.00 -0.97 0.06 0.61
5-Hydroxytryptamine 2b Receptor 18 Target Disease Central Nervous System Diseases 715 1 0.01 -0.97 0.06 0.70
5-Hydroxytryptamine 2b Receptor 18 Target Disease Amyotrophic Lateral Sclerosis 14,006 1 0.00 -0.97 0.06 0.62
5-Hydroxytryptamine 2b Receptor 18 Target Disease Migraine 24,200 1 0.00 -0.97 0.06 0.61
5-Hydroxytryptamine 2b Receptor 18 Target Disease Liver Disease 49,817 1 0.00 -0.97 0.06 0.59
5-Hydroxytryptamine 2b Receptor 18 Target Disease Obesity 138,233 1 0.00 -0.97 0.06 0.57
5-Hydroxytryptamine 2a Receptor 67 Target Target Sphingomyelinase 3,060 1 0.00 -0.99 0.01 0.64
5-Hydroxytryptamine 2a Receptor 67 Target Target BDNF 11,163 1 0.00 -0.99 0.01 0.60
5-Hydroxytryptamine 2a Receptor 67 Target Target EGF 27,487 1 0.00 -0.99 0.01 0.58
5-Hydroxytryptamine 2a Receptor 67 Target Target Collagen 138,882 1 0.00 -0.99 0.01 0.55
5-Hydroxytryptamine 2a Receptor 67 Target Disease Mania 7,698 1 0.00 -0.99 0.01 0.61
5-Hydroxytryptamine 2a Receptor 67 Target Disease Autism 20,962 1 0.00 -0.99 0.01 0.59
5-Hydroxytryptamine 2a Receptor 67 Target Disease Psoriasis 26,882 1 0.00 -0.99 0.01 0.58
5-Hydroxytryptamine 2a Receptor 67 Target Disease Seizures 66,465 1 0.00 -0.99 0.01 0.56
5-Hydroxytryptamine 2a Receptor 67 Target Disease Inflammation 252,734 1 0.00 -0.99 0.01 0.53
464.1 19 Target Disease Hypotension 42,123 1 0.00 -0.97 0.05 0.59
464.1 19 Target Disease Asthma 109,610 1 0.00 -0.97 0.05 0.57
464.1 19 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
464.1 19 Target Disease Cholesterol 182,390 1 0.00 -0.97 0.05 0.56
464.1 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
4-Mercaptopyridine 96 Drug Drug Doxorubicin 28,033 1 0.00 -0.99 0.01 0.58
4-Mercaptopyridine 96 Drug Disease Glioblastoma 17,933 1 0.00 -0.99 0.01 0.59
4-Mercaptopyridine 96 Drug Disease Cancer 1,053,491 1 0.00 -0.99 0.01 0.50
4-Mercaptobenzoic Acid 70 Drug Disease Malaria 56,215 1 0.00 -0.99 0.01 0.56
4-1BB Receptor 20 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
4-1BB Receptor 20 Target Disease Conjunctivitis 8,825 1 0.00 -0.97 0.05 0.63
4-1BB Receptor 20 Target Disease Lung Carcinoma 13,423 1 0.00 -0.97 0.05 0.62
4-1BB Receptor 20 Target Disease Influenza 67,933 1 0.00 -0.97 0.05 0.58
4-1BB Receptor 20 Target Disease Shock 134,031 1 0.00 -0.97 0.05 0.57
4-1BB Receptor 20 Target Disease Tuberculosis 146,217 1 0.00 -0.97 0.05 0.56
4-1BB Receptor 20 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
4-1BB Receptor 20 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
4-1BB Ligand 135 Target Target BTK 1,263 1 0.00 -1.00 0.01 0.65
4-1BB Ligand 135 Target Target CCL3 1,427 1 0.00 -1.00 0.01 0.65
4-1BB Ligand 135 Target Target Collagen 138,882 1 0.00 -1.00 0.01 0.53
4-1BB Ligand 135 Target Drug Doxorubicin 28,033 1 0.00 -1.00 0.01 0.57